ANDA 40297, held by Usl Pharma. Estradiol.
As of Nov 14, 2026, ANDA 40297 (Estradiol), held by Usl Pharma, was first approved by FDA on Apr 17, 2002, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 17, 2002 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
